Skip to main content

and
  1. Article

    Open Access

    Examining confidential wholesale margin estimates in European countries for the price negotiation of patented drugs in Germany: a statistical model

    Based on the legal framework laid down in section 130b (9) of Book V of the German Social Code, various criteria are relevant for the negotiated price for new patented drugs in Germany. European reference pric...

    Iris an der Heiden, Guido Schiffhorst, Laura Müller in Health Economics Review (2024)

  2. Article

    Open Access

    Can adaptive clinical trials help to solve the productivity crisis of the pharmaceutical industry? - a scenario analysis

    The productivity of pharmaceutical research and development (R&D) investments is declining due to high failure rates in clinical research. Recently, the US Food and Drug Administration (FDA) acknowledged that ...

    Jörg Mahlich, Arne Bartol, Srirangan Dheban in Health Economics Review (2021)